VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,609,161 | -61.8% | 1,559,142 | 0.0% | 17.42% | -42.8% |
| Q2 2023 | $38,245,753 | +5.4% | 1,559,142 | 0.0% | 30.44% | -5.0% |
| Q1 2023 | $36,281,234 | -8.1% | 1,559,142 | 0.0% | 32.04% | +5.4% |
| Q4 2022 | $39,461,884 | +31.1% | 1,559,142 | 0.0% | 30.41% | +27.8% |
| Q3 2022 | $30,100,000 | -24.2% | 1,559,142 | 0.0% | 23.79% | -22.0% |
| Q2 2022 | $39,700,000 | -1.0% | 1,559,142 | 0.0% | 30.52% | +41.5% |
| Q1 2022 | $40,100,000 | +41.2% | 1,559,142 | +130.0% | 21.56% | +150.2% |
| Q4 2021 | $28,400,000 | -3.7% | 677,777 | 0.0% | 8.62% | -0.2% |
| Q3 2021 | $29,500,000 | -77.5% | 677,777 | -75.6% | 8.64% | -57.1% |
| Q2 2021 | $131,000,000 | -8.0% | 2,777,777 | 0.0% | 20.13% | -13.6% |
| Q1 2021 | $142,417,000 | +92.5% | 2,777,777 | 0.0% | 23.30% | +37.9% |
| Q4 2020 | $74,000,000 | – | 2,777,777 | – | 16.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |